Mineralys Therapeutics, Inc. (MLYS)
24.07
+0.79
(+3.39%)
USD |
NASDAQ |
Mar 20, 16:00
24.06
-0.01
(-0.04%)
After-Hours: 20:00
Mineralys Therapeutics Total Assets (Quarterly) : 661.81M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Insmed, Inc. | 2.265B |
| Nektar Therapeutics | 280.41M |
| Syndax Pharmaceuticals, Inc. | 529.71M |
| Cogent Biosciences, Inc. | 937.61M |
| Lyell Immunopharma, Inc. | 340.05M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 15.11M |
| Shareholders Equity (Quarterly) | 646.69M |
| Current Ratio | 43.76 |